Latest multiple myeloma news
Racial Disparities Persist in Multiple Myeloma Care, Outcomes
posted July 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Response to COVID-19 Vaccine Variable in Multiple Myeloma Patients
posted July 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Efficacy of BNT162b2 mRNA COVID-19 Vaccine Lower in Patients With CLL
posted May 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
First Cell-Based Gene Therapy Approved for Multiple Myeloma
posted March 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Aglatimagene Besadenovec + Valacyclovir Ups DFS in Localized Prostate Cancer 
Lentiviral Gene Therapy Shows Sustained Clinical Efficacy for ADA-SCID 
Exa-Cel Gene Therapy Improves Quality of Life in Severe Sickle Cell Disease 
Alternative to Lenalidomide ID'd for Maintenance in Multiple Myeloma 
Inflammatory-Nutritional Score Helps Predict Survival in New Multiple Myeloma 
Body Mass Index Tied to Multiple Myeloma Survival Monthly Specialist Briefings
Stay Connected
